Erysipelas: A common potentially dangerous infection

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 16, Issue 3, 2007, Pages 123-127

  Celestin, Ruth ^a   Brown, Justin ^a   Kihiczak, George ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Erysipelas; Review; Streptococcal infection

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BENZATHINE PENICILLIN; COCODAMOL; CORTICOSTEROID; ERYTHROMYCIN; GENTAMICIN; IBUPROFEN; PARACETAMOL; PENICILLIN DERIVATIVE; PREDNISOLONE; PSEUDOMONIC ACID;

ABSCESS; AGE; ARTICLE; CELLULITIS; CHILL; CONVALESCENCE; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ERYSIPELAS; ERYTHEMA; FEVER; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; LYMPHEDEMA; MALAISE; NECROTIZING FASCIITIS; NEPHROTIC SYNDROME; NONHUMAN; RECURRENT INFECTION; RISK FACTOR; SEPTICEMIA; STREPTOCOCCUS GROUP A; SYMPTOMATOLOGY;

AGED; ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; ERYSIPELAS; HUMANS; INFANT; INFANT, NEWBORN; MALE; RISK FACTORS; SKIN; SKIN DISEASES, INFECTIOUS;

EID: 35448986528     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Delbanco E, Callomon F. Erysipel. In: Jadassohn J, editor. Handbuch der Haut- und Geschlechtskrankheiten, Vol IX.1. Berlin: Springer; 1929. p. 1-85.
2. Grosshans E. The red face: erysipelas. Clin Dermatol 1993;11:307-13.
3. Bratton RL, Nesse RE. St Anthony's fire: diagnosis and management of erysipelas. Am Fam Physician 1995;51:401-4.
4. Ligtenberg G, Blankestijn PJ, Koomans HA. Erysipelas: not always innocent. Neth J Med 1993;43:179-82.
5. Morris, A. Cellulitis and erysipelas. Clin Evid 2004;12:2271-7.
6. el Tayeb SH, el Soliman AA, el Sehrawy AS. Role of Streptococcus pyogenes in the etiology of erysipelas. Adv Exp Med Biol 1997;418:95-7.
7. Kihiczak GG, Schwarte RA, Kapila R: Necrotizing fasciitis: a deadly infection. J Eur Acad Dermatol Venereol 2006;20:365-9.
8. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996;334:240-5.
9. Mossad, S. Common infections in clinical practice: dealing with the daily uncertainties. Cleve Clin J Med 2004;71:129-30, 133-8, 141-3.
10. Trebing D, Goring HD. Wound healing of chronic leg ulcers under the influence of erysipelas. Eur J Dermatol 2004;14:56-7.
11. Bonnetblanc JM, Bedane C. Erysipelas: recognition and management. Am J Clin Dermatol 2003;4:157-163.
12. Bishara J, Golan-Cohen A, Robenshtok E, Leibovici L, Pitlik S. Antibiotic use in patients with erysipelas: a retrospective study. Isr Med Assoc J 2001;3:722-4.
13. Danik SB, Schwartz RA, Oleske JM. Cellulitis. Cutis 1999;64:157-60, 163-4.
14. Sadick NS. Current aspects of bacterial infections of the skin. Dermatol Clin 1997;15:341-9.
15. Chartier C, Grosshans E. Erysipelas: an update. Int J Dermatol 1996;35:779-81.
16. Walsh S. Boy with a facial rash: erysipelas. J Pediatr Health Care 1999;13:40, 48.
17. Murray AH. Differential diagnosis of a red face. J Cutan Med Surg 1998;4:S4-11-5.
18. Guberman D, Gilead LT, Zlotogorski A, Schamroth J. Bullous erysipelas: a retrospective study of 26 patients. J Am Acad Dermatol 1999;41:733-7.
19. Eriksson B, Jorup-Ronstrom C, Karkkonen K, Sjoblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clin Infect Dis 1996;23:1091-8.
20. Leppard BJ, Seal DV, Colman G. The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol 1985;112:559-67.
21. Jorup-Ronstrom C. Epidemiological, bacteriological and complicating features of erysipelas. Scand J Infect Dis 1986;18:519-24.
22. Stibich AS, Carbonaro PA, Schwarte RA. Insect bite reactions: an update. Dermatology 2001;202:193-7.
23. Chateinikolaou I, Abi-Said D, Bodey GP, et al. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med 2000;160:501.
24. Brooke CJ, Riley TV. Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen. J Med Microbiol 1999;48:789-99.
25. Schwarte R, Das-Young LR, Ramirez-Ronda C, Frank E. Current and future management of serious skin and skin-structure infections. Am J Med 1996;100:90S-5S.
26. Brook I, Frazier EH. Clinical and microbiologic findings of necrotizing fascitis. J Clin Microbiol 1995;33:2382-7.
27. Bergkvist P I, Sjobeck K Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up. Scand J Infect Dis 1998;30:206-7.
28. Dall L, Peterson S, Simmons T, Dall A. Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy. Cutis 2005;75:177-80.
29. Eriksson BK. Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity. Clin Infect Dis 1999;29:1319-20.
30. Sjoblom AC, Eriksson B, Jorup-Ronstrom C et al. Antibiotic prophylaxis in recurrent erysipelas. Infection 1993;21:390-3.
31. Proske S, Uter W, Schwanitz HJ. Lymphedema of the hand following recurrent erysipelas secondary to fissured irritant contact dermatitis. Contact Derm 2000;42:368-9.